11th Annual AACI CRI Meeting
Strategies to Maximize Innovation to Advance Cancer Clinical Research
July 9-11, 2019
Chicago, IL
With more than a decade of consistent growth, the Association of American Cancer Institutes (AACI) Clinical Research Innovation (CRI) program has expanded from an initiative into a permanent fixture among cancer center clinical trials professionals. To recognize CRI’s pioneering efforts to develop and disseminate best practices for cancer clinical trials, AACI renamed the program "Clinical Research Innovation" in 2018. CRI’s forward momentum also drives the programming of the 11th Annual AACI CRI Meeting, titled "Strategies to Maximize Innovation and Advance Cancer Clinical Research."
The CRI annual meeting program aligns with AACI's strategic goal of stimulating cancer center interactions to maximize resources by creating opportunities for peer-to-peer networking and collaboration. CRI participants fill a variety of leadership roles and possess a comprehensive understanding of the clinical trials system.
- Practice mind-body coordination to enhance self-awareness, build resiliency, and reduce burnout
- Learn how to effectively run multicenter clinical trials
- Learn and apply conflict-resolutions skills to help team members reach their full potential
- Discuss approaches for matching patients who have genomic mutations with clinical trials
- Discuss key pre- and post-activation steps in clinical trials, such as reviewing trial feasibility and developing consistent policies for closing trials
- Learn how cancer center leaders have used clinical trial data to analyze downstream revenue and demonstrate the value of the CTO to hospital and institutional administrators
- Explore innovative solutions to common challenges that arise during trial start-up
- Discuss strategies for enrolling patients from diverse backgrounds to clinical trials and the challenges that prevent cancer centers from reaching their recruitment goals
- Prepare a successful National Cancer Institute (NCI) Cancer Center Support Grant (CCSG) application
- Individuals from AACI member cancer centers
- Administrative directors of clinical trials offices (CTO)
- CTO medical directors
- Deputy/associate directors of clinical research administration
- Cancer center administrators
- CTO managers and supervisors
- Research regulatory management and staff
- Clinical research finance directors, managers, and supervisors
- Biostatisticians and informatics specialists
- NCI and other government agencies, (e.g., FDA, HHS, etc.)
- AACI sustaining members
- AACI Corporate Roundtable members
- Representatives from industry (e.g., drug development companies, clinical research organizations (CRO, consultants, etc.)
- IT companies that support cancer center clinical research management
- Like-minded organizations promoting patient access to clinical trials